NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 75 filers reported holding NOVELION THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $31,000 | -55.7% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $70,000 | -59.3% | 10,000 | -46.2% | 0.00% | -50.0% |
| Q2 2017 | $172,000 | -14.0% | 18,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $200,000 | -31.0% | 18,600 | -46.1% | 0.00% | -50.0% |
| Q4 2016 | $290,000 | – | 34,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|